Serina Therapeutics, Inc. Operating Margin in % from 2017 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Serina Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2017 to Q3 2025.
  • Serina Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2025 was -20.1K %, a 5548% decline year-over-year.
  • Serina Therapeutics, Inc. annual Operating Margin for 2024 was -30.4K %, a 30576% decline from 2023.
  • Serina Therapeutics, Inc. annual Operating Margin for 2023 was -99.2 %, a 99.5% increase from 2022.
  • Serina Therapeutics, Inc. annual Operating Margin for 2022 was -20.5K %, a 272% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)

Serina Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -20.1K -19.8K -5548% Jul 1, 2025 Sep 30, 2025
Q2 2025 -17.1K -16.9K -7239% Apr 1, 2025 Jun 30, 2025
Q1 2025 -40.4K -40.2K -28032% Jan 1, 2025 Mar 31, 2025
Q4 2024 -30.4K -30.3K -30576% Oct 1, 2024 Dec 31, 2024
Q3 2024 -357 +6.61K +94.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 -234 +9.47K +97.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -143 +9.83K +98.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -99.2 +20.4K +99.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -6.96K +6.36K +47.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -9.7K +863 +8.17% Apr 1, 2023 Jun 30, 2023
Q1 2023 -9.97K -1.59K -19% Jan 1, 2023 Mar 31, 2023
Q4 2022 -20.5K -15K -272% Oct 1, 2022 Dec 31, 2022
Q3 2022 -13.3K -10.3K -336% Jul 1, 2022 Sep 30, 2022
Q2 2022 -10.6K -7.72K -271% Apr 1, 2022 Jun 30, 2022
Q1 2022 -8.38K -5.56K -196% Jan 1, 2022 Mar 31, 2022
Q4 2021 -5.51K -2.71K -96.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -3.05K -1.66K -119% Jul 1, 2021 Sep 30, 2021
Q2 2021 -2.85K -1.81K -174% Apr 1, 2021 Jun 30, 2021
Q1 2021 -2.83K -1.96K -225% Jan 1, 2021 Mar 31, 2021
Q4 2020 -2.8K -2.07K -285% Oct 1, 2020 Dec 31, 2020
Q3 2020 -1.39K -510 -57.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.04K -210 -25.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -871 -171 -24.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -727 +78.7 +9.77% Oct 1, 2019 Dec 31, 2019
Q3 2019 -885 Jul 1, 2019 Sep 30, 2019
Q2 2019 -830 Apr 1, 2019 Jun 30, 2019
Q1 2019 -700 Jan 1, 2019 Mar 31, 2019
Q4 2018 -806 Oct 1, 2018 Dec 31, 2018

Serina Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -30.4K -30.3K -30576% Jan 1, 2024 Dec 31, 2024
2023 -99.2 +20.4K +99.5% Jan 1, 2023 Dec 31, 2023
2022 -20.5K -15K -272% Jan 1, 2022 Dec 31, 2022
2021 -5.51K -2.71K -96.9% Jan 1, 2021 Dec 31, 2021
2020 -2.8K -2.07K -285% Jan 1, 2020 Dec 31, 2020
2019 -727 +78.7 +9.77% Jan 1, 2019 Dec 31, 2019
2018 -806 -331 -69.7% Jan 1, 2018 Dec 31, 2018
2017 -475 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.